Equities
India stocks little changed as investors analyze state poll verdict, inflation data
Prime Minister Modi's BJP may fall short of majority in Karnataka
Welcome to our new website
As well as being able to load content faster than ever before, you'll now find it's much easier to find all the content you need about the Asian business world.
Pharmaceuticals
Business Deals
Ominous earnings outlook boosts Takeda's case for Shire bid
Irish peer is potential lifeline as profitability lags behind competition
Equities
India shares little changed as Karnataka exit polls remain inconclusive
Investors await election results due Tuesday
Companies
Fujifilm to raise stake in drug unit to 100%
The $600m deal will create expanded pharma business for big bet on health care
Business Deals
Takeda-Shire deal shows it's US or bust for Japanese drugmakers
Will an aging Japan be left with a hollow pharmaceutical industry?
Business Deals
Goldman and Nomura lead all-star team behind Takeda-Shire deal
US and Japanese M&A advisers poised for $180m payday
Business Deals
Takeda chief says Shire takeover will bear fruit in first year
Weber foresees $1.4bn in annual cost savings
Business Deals
Takeda borrows $31bn for Shire buyout but vows to deleverage
Japanese drugmaker plans to cut debt by half in 3-5 years to keep credit rating
Business Deals
Takeda closes in on $62bn deal for Shire
Japanese drugmaker to make cash-and-stock offer on Tuesday for Irish peer
